4//SEC Filing
DEMANE MICHAEL F 4
Accession 0001610717-24-000261
CIK 0001444380other
Filed
May 27, 8:00 PM ET
Accepted
May 28, 6:53 PM ET
Size
9.0 KB
Accession
0001610717-24-000261
Insider Transaction Report
Form 4
NEVRO CORPNVRO
DEMANE MICHAEL F
DirectorChief Executive Officer
Transactions
- Award
Common Stock
2024-05-23+19,169→ 46,995 total
Holdings
- 164,344(indirect: See footnote)
Common Stock
- 219,145(indirect: See footnote)
Common Stock
- 58,266(indirect: See footnote)
Common Stock
- 0(indirect: See footnote)
Common Stock
Footnotes (9)
- [F1]Constitute restricted stock units ("RSUs") for which the Reporting Person is entitled to receive one (1) share of Common Stock for each RSU upon vesting. 100% of the RSUs shall vest on the earlier of (i) one year anniversary of May 23, 2024 or (ii) the next Annual Meeting following May 23, 2024, subject to the Reporting Person's continued service to the Issuer.
- [F2]Includes 19,169 RSUs.
- [F3]Shares held by Catherine Q. DeMane Trustee, Michael F. DeMane 2012 Irrevocable Trust U/A/D July 26, 2012.
- [F4]Shares held by Catherine Q. DeMane Trustee, Michael F. DeMane 2017 Family SLAT Trust U/A/D May 22, 2017 (the "SLAT Trust").
- [F5]Shares held by Michael F. DeMane & Catherine Q. DeMane, Trustees, Michael F. DeMane Revocable Trust U/A 10/07/2011 (the "2011 Trust").
- [F6]Shares held by Michael F. DeMane, Trustee, Michael F. DeMane 2021 Retained Annuity Trust U/A 08/13/2021 (the "2021 Trust").
- [F7]Reflects the transfer of 5,379 directly held shares to the SLAT Trust on June 6, 2023.
- [F8]Reflects the transfer of 91,225 shares from the 2011 Trust to the SLAT Trust on June 6, 2023.
- [F9]Reflects the transfer of 18,266 shares from the 2021 Trust to the 2011 Trust on November 24, 2023.
Documents
Issuer
NEVRO CORP
CIK 0001444380
Entity typeother
Related Parties
1- filerCIK 0001174533
Filing Metadata
- Form type
- 4
- Filed
- May 27, 8:00 PM ET
- Accepted
- May 28, 6:53 PM ET
- Size
- 9.0 KB